Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served as a platform for groundbreaking research, clinical insights and news that have helped shape the […]

Antioxidant enzymes as potential targets in cardioprotection and treatment of cardiovascular diseases. Enzyme antioxidants: the next stage of pharmacological counterwork to the oxidative stress

Alexander V. Maksimenko, Alexander V. Vavaev
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Aug 7th 2018 Heart International 2012;7(1):e3 DOI: https://doi.org/10.4081/hi.2012.e3
Select a Section…
1

Abstract

Overview

The focus in antioxidant research is on
enzyme derivative investigations. Extracellular
superoxide dismutase (EC-SOD) is of particular
interest, as it demonstrates in vivo the
protective action against development of atherosclerosis,
hypertension, heart failure, diabetes
mellitus. The reliable association of
coronary artery disease with decreased level of
heparin-released EC-SOD was established in
clinical research. To create a base for and to
develop antioxidant therapy, various SOD
isozymes, catalase (CAT), methods of gene
therapy, and combined applications of
enzymes are used. Covalent bienzyme SODCHS-
CAT conjugate (CHS, chondroitin sulphate)
showed high efficacy and safety as the
drug candidate. There is an evident trend to
use the components of glycocalyx and extracellular
matrix for target delivery of medical
substances. Development of new enzyme
antioxidants for therapeutic application is
closely connected with progress in medical
biotechnology, pharmaceutical industry, and
bioeconomy.

Keywords

Reactive oxygen species, enzyme antioxidants, oxidative stress, cardiovascular diseases, vascular wall injury, endothelial glycocalyx, extracellular superoxide dismutase, catalase, novel bienzyme superoxide dismutase – chondroitin sulphate – catalase conj

2

Article Information

Correspondence

Alexander V. Maksimenko, Institute of Experimental Cardiology, Russian Cardiology Research-and-Production Complex, 3- rd Cherepkovskaya Street 15A, 121 552 Moscow, Russia Tel. +7.495.414.60.25 – Fax: +7.499.726.31.16. E-mail: alexmak@cardio.ru

Acknowledgements

The authors sincerely thank
and highly appreciate the support of research and
efficient discussions with professors EI Chazov,
VN Smirnov, AM Egorov, EV Arzamastcev, VI
Kapelko, VZ Lankin, EK Ruuge, AK Tichaze. This
work was performed thanks to the support of the
grants of Russian Foundation for Basic Research
07-04-12057-ofi, 09-08-00023, Rosmedtechnologies
Agency and Roszdravsozrazvitija Ministry of
Russian Federation.

Received

2011-06-16

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup